Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-10-2
pubmed:abstractText
Immune/inflammatory factors have been implicated in the pathogenesis of Parkinson's disease (PD). Immunoglobulin G (IgG) from patients with PD can induce injury of dopaminergic neurons following stereotaxic injection into rat substantia nigra (SN). The PD IgG can be demonstrated in vitro to activate microglia via the Fcgamma receptor (Fcgamma R) and induce dopaminergic cell injury. To confirm the involvement of microglia and their Fcgamma R in IgG-induced lesions of SN in vivo we analyzed the tyrosine hydroxylase (TH)-positive cell loss in SN par compacta (SNpc) in mice lacking Fcgamma receptors (Fcgamma R(-/-)) and wild type (Fcgamma R(+/+)). At 1 day after stereotaxic injection of PD IgG into the SN of Fcgamma R(+/+) mice there was a 27% increase in the number of CD11b-positive microglial cells and no significant loss of TH-positive cells. At 14 days after the stereotaxic injection, the number of microglial cells was increased by 42%, accompanied by a 40% loss of TH-positive neurons in the SNpc. PD IgG injection in Fcgamma R(-/-) mice resulted in no significant increase of microglia and no loss of TH-positive cells in the SNpc at any time point. The injection of F(ab')(2) fragments of PD IgG was able to induce TH-positive neuronal loss in the SNpc only when the injected animals raised antibodies against the injected human IgG fragments, which confirmed the importance of the Fcgamma R in microglial activation and nigral injury.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0014-4886
pubmed:author
pubmed:issnType
Print
pubmed:volume
176
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
322-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12359173-Animals, pubmed-meshheading:12359173-Antibodies, pubmed-meshheading:12359173-Cell Count, pubmed-meshheading:12359173-Homozygote, pubmed-meshheading:12359173-Humans, pubmed-meshheading:12359173-Immunoglobulin Fab Fragments, pubmed-meshheading:12359173-Immunoglobulin G, pubmed-meshheading:12359173-Macrophage-1 Antigen, pubmed-meshheading:12359173-Male, pubmed-meshheading:12359173-Mice, pubmed-meshheading:12359173-Mice, Inbred C57BL, pubmed-meshheading:12359173-Mice, Knockout, pubmed-meshheading:12359173-Microglia, pubmed-meshheading:12359173-Microinjections, pubmed-meshheading:12359173-Neurons, pubmed-meshheading:12359173-Parkinson Disease, pubmed-meshheading:12359173-Receptors, IgG, pubmed-meshheading:12359173-Stereotaxic Techniques, pubmed-meshheading:12359173-Substantia Nigra, pubmed-meshheading:12359173-Time Factors, pubmed-meshheading:12359173-Tyrosine 3-Monooxygenase
pubmed:year
2002
pubmed:articleTitle
Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra.
pubmed:affiliation
Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't